Table 2. Summary of Included Studies

First Author (Year) C* & T Samples Treatment Methods Treatment Period Outcome Measurement Result & P value Side Effects
Yin10) (2007) C : 30 Amoxicillin 5 days 1. TER2. Onset of Effect3. Recovery Time 1. T>C(p<0.05) C : 86.7%  T : 94%2. T>C(p<0.05) C : (3.48±0.58)h  T : (1.52±0.71)h3. T>C(p>0.05) C : (4.5±2.07)d  T : (4.13±1.31)d NR
T : 100 Cheongin-tang
Pan11) (2010) C : 60 Cefuroxime Axetil 3 days 1. TER 1. T>C(p=0.036, p<0.05) C : 80.0%  T : 95.0% NR
T : 60 Yukmi-tang
Liu12) (2012) C : 35 Cephalexin Capsule 10 days 1. TER 1. T>C(p=0.036, p<0.05) C : 68.6%  T : 97.1% NR
T : 68 Yukmi-tang
Jang13) (2012) C : 45 Roxithromycin Capsule 5 days 1. TER 1. T>C(p<0.01) C : 88.88%  T : 95.55% NR
T : 45 Eungyo-san
Wang14) (2013) C : 62 Cephalexin Capsule 7 days 1. TER 1. T>C(p<0.05) C : 82.26%  T : 96.77% C : 11.29%T : 3.23%
T : 62 Gyoha-tang
Zhong15) (2016) C : 60 Cefuroxime Axetil 5 days 1. TER2. Symptom Score ① Sore Throat ② Throat Burning Sensation ③ Pharyngeal examination3. Peripheral Blood Percentage ① WBC ② Neutrophils 1. T>C(p>0.05) C : 90.0%  T : 91.7%2. T>C(p<0.001) ① C : 3.55±1.06 → 2.30±0.79 T : 3.60±0.95 → 1.16±0.62 ② C : 2.82±1.26 → 1.59±0.72 T : 2.65±1.33 → 0.35±0.77 ③ C : 3.93±1.07 → 2.35±0.75 T : 3.80±1.21 → 1.10±0.783. ① T>C(p>0.05) C : 8.01±2.45 → 6.31±1.65 T ; 8.13±2.37 → 6.23±1.78 ② T>C(p<0.05)C : 73.21±3.12 → 62.12±2.45T : 72.30±3.05 → 61.35±2.13 C : 0%T : 0%
T : 60 Sigeumyiin-tang
Guo16) (2017) C : 30 Amoxicillin 7 days 1. TER2. Symptom Score 1. T>C(p<0.05) C : 83.33%  T ; 93.94%2. T>C(p<0.01) C : 19.80±4.05 → 4.62±1.34 T : 20.73±3.86 → 2.81±1.59 NR
T : 33 Cheonginchisi-tang
Li17) (2017) C : 30 Amoxicillin 5 days 1. TER2. Symptom Score ① Sore Throat ② Pharyngeal Dryness and Burning Sensation ③ Pharyngeal Mucosal Congestion ④ Cough ⑤ Sputum ⑥ Overall 1. T>C(p<0.05) C : 73.3%  T : 90.3%2. T>C(p<0.05)① C :2.70±0.47 → 1.40±0.68 T : 2.93±0.25 → 0.77±0.82② C : 2.57±0.50 → 1.23±0.63 T : 2.70±0.47 → 0.77±0.82③ C : 2.57±0.57 → 1.47±0.63 T : 2.73±0.57 → 1.17±0.15④ C : 2.10±0.55 → 0.83±0.59 T : 2.47±0.57 → 0.27±0.45⑤ C : 2.23±0.63 → 1.0 0±0.79 T : 2.43±0.63 → 0.50±0.78⑥ C :12.10±0.92 → 6.00±2.21 T : 13.27±1. 31 → 3.43±2.42 C : 26.7%T : 6.7%
T : 30 Cheonginhadam-tang
Zhou18) (2019) C : 40 Compound BoraxGargle & Amoxicillin 7 days 1. TER2. Symptom Score3. Peripheral Blood Percentage ① WBC ② Neutrophils4. Ratio of Peripheral Blood ① IL-2 ② IL-12 ③ IFN-a 1. T>C(p<0.05) C : 87.50%  T : 95.00%2. T>C(p<0.05) C : 21.87±4.38 → 5.68±3.65 T : 20.62±4.61 → 3.26±2.243. T>C(p<0.05)① C : 10.73±1.61 → 6.21±1.79 T : 10.56±1.50 → 6.27±1.76② C : 80.08±4.68 → 58.39±9.25 T : 79.98±4.66 → 57.52±9.024. T>C(p<0.05)① C : 65.58±20.32 → 70.36±20.08 T : 65.56± 20.31 → 73.98±20.06② C : 7.20±1.85 → 7.99±3.02 T : 7.18± 1.84 → 9.05±3.04③ C : 30.17±9.66 → 35.63±10.69 T : 30.15±9.67 → 39.15±10.47 C : 0%T : 0%
T : 40 Daecheongin-tang
C : Control,
T : Treatment,
TER : Total Effective Rate